Assessment of degree of risk from sources of microbial contamination in cleanrooms; 2: surfaces and liquids by Whyte, W. & Eaton, T.
117
*Corresponding author:Tim Eaton, Sterile Manufacturing Specialist,
AstraZeneca, UK Operations, Silk Road Business Park, Macclesfield,
Cheshire, SK10 2NA; Email: tim.eaton@astrazeneca.com; Tel: +44(0)1625
514916.   
European Journal of Parenteral & Pharmaceutical Sciences 2014; 20(4): 117-126
2015 Pharmaceutical and Healthcare Sciences Society
W Whyte1 and T Eaton2*
1 James Watt Building South, University of Glasgow, UK  
2 AstraZeneca, Macclesfield, UK
Assessment of degree of risk from sources of
microbial contamination in cleanrooms; 2:
Surfaces and liquids
Introduction
The requirements for minimising microbial contamination in
pharmaceutical cleanrooms are outlined in regulatory
documents published by authorities that include the European
Commission1 and the Food and Drug Administration in the
USA2. These authorities also suggest the use of risk
management and assessment techniques to identify and
control sources of microbial contamination3,4. Risk
assessment and management methods have been investigated
by the authors of this article5–9 and other approaches are
discussed by Mollah et al10.
Risk assessment methods are used to calculate the degree
of risk to the product from microbial sources in a cleanroom.
Factors that influence risk are determined and assigned
descriptors of risk, which are of the ‘high’, ‘medium’, and
‘low’ type that act as surrogates for actual numerical values.
Numerical scores are assigned to these descriptors and the
scores combined, usually by multiplication, to obtain a risk
assessment for each source of contamination. However, a risk
assessment carried out in this manner may not be accurate, for
the following reasons.
• Assigning risk descriptors and risk scores is subjective.
• The way the risk scores are combined may not reflect the
actual mechanism of contamination.
• Differences between the transfer mechanisms of air,
surface contact and liquid make it difficult for these types
of risks to be compared.
It would be beneficial if a risk assessment method was
available that avoided these short comings, and could calculate
the contamination rate of products from the various sources in
a cleanroom. A previous article by Whyte and Eaton11
discussed the application of such a method to airborne sources
of microbe-carrying particles (MCPs). This article considers
the application of the method to surface and liquid sources.
Calculation of microbial deposition onto a
product
Risk is defined12 as the product of the ‘severity’ (also known
as ‘criticality’) of harm and the ‘probability’ of occurrence,
and its magnitude can be determined by multiplying together
values assigned to these two variables. 
The degree of risk from microbial contamination of manufactured products in healthcare
cleanrooms has been assessed in a series of three articles. The first article discussed airborne sources,
and this second article considers surface contact and liquid sources. A final article will consider all
sources and give further information on the application of the risk method.
The degree of risk to products from micro-organisms transferred from sources by surface
contact, or by liquids, has been assessed by the means of fundamental equations used to calculate the
likely number of microbes deposited (NMD) onto, or into, a product. The method calculates the likely
product contamination rate from each source and gives a more accurate risk assessment than those
presently available. It also allows a direct comparison to be made between microbial transfer by
different routes, i.e. surface, liquid and air.
Key words:Risk assessment, degree of risk, source, surface contact, contamination, micro-organisms,
microbes, MCPs.
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Equation 1
Degree of risk = severity of harm × probability of harm
In the context of microbial contamination of products in a
cleanroom, ‘severity’  can be considered as the product of
the concentration of microbes in, or on, a source of
contamination, and the likelihood that these microbes will
be transferred to a product. The ‘probability’ can usually
be considered in (a) airborne contamination as the time the
product is exposed to contamination, (b) surface
contamination as the number of contacts, and (c) liquid
contamination as continuous.
Fundamental risk factor equations have been derived by
Whyte and Eaton7,11 to calculate the number of microbes that
deposit onto, or into, a product from air, surface contact, or
liquids. These equations calculate the number of microbes
deposited (NMD) onto, or into, one product unit, and
typically give a numerical value well below one. The NMD
in this article uses the format 1 x 10-6 but it can be
alternatively given as a product contamination rate of 1 in
106, or 1 in a million units. It is important to make sure that
the units of measurement are consistent in the risk equations,
and those mainly used in this article are centimetres and
seconds, although metres and seconds are also used.
Equation 2 has been derived by Whyte and Eaton7, 11 to
calculate the NMDA from air sources.
Equation 2; Airborne
NMDA = c*p*a*t*sv
Where, NMDA = number of airborne MCPs deposited onto a
single product, c = concentration of microbes in the airborne
source, p = transfer coefficient of MCPs transmitted from
source to product, a = area of product exposed to microbial
deposition, t = time of exposure to airborne deposition, and
s
v
= settling velocity of MCPs through air.
The settling velocity (s
v
) is the rate that MCPs fall through
the air, and has been discussed and used in the previous
article11. Microbes do not normally exist in the air as
single cells. They are mainly dispersed on skin particles
by personnel and have an average aerodynamic diameter
of about 12 µm13,14, with an average deposition velocity of
about 0.46 cm/s15.
Equation 3 can be used to calculate the NMDSC from
surfaces.
Equation 3; Surface contact
NMDSC = c*p*a*n
Where, NMDSC = number of MCPs deposited onto a
single product by surface contact, c = concentration of
MCPs on the surface of a source, p = transfer coefficient
of MCPs from donating to receiving surface, a = area of
contact, and n = number of contacts.
Equation 3 is used to calculate the NMDSC onto a
product by surface contact. Much of the information
required to solve Equation 3 will be known, or can be
measured. The proportion of microbes on the donating
surface, which are transferred to a receiving surface or
product, is known as the transfer coefficient. Whyte and
Eaton16 have carried out experiments using skin-derived
MCPs to obtain transfer coefficients and the following
average values were obtained: gloves to stainless steel =
0.19, stainless steel to stainless steel = 0.10, and clothing to
stainless steel = 0.06. The contact between stainless steel
and glass is between hard surfaces and assumed to have a
similar value to that between stainless steel and stainless
steel. As these coefficients have similar values, and for
simplification, a worst case transfer coefficient of 0.2 was
used in all surface transfers considered in this paper.
Equation 4 can be used to calculate the NMDL from
liquid sources.
Equation 4; Liquid
NMDL = c*p*v
Where, NMDL = number of liquid-borne microbes
deposited into a single product, c = concentration of
microbes in a liquid source, p = transfer coefficient of
microbes from source to product, and v = volume of liquid
deposited into product.
Description of cleanroom studied 
In the first article of this series, Whyte and Eaton11
described a method of calculating the NMDA from
airborne sources of microbes, and illustrated it with a
pharmaceutical cleanroom used to aseptically fill batches
of pharmaceutical products in a unidirectional air flow
(UDAF) workstation. The same example will again be
used to calculate the NMD from surfaces and liquids.
Cleanrooms that control microbial contamination use a
variety of designs and manufacturing methods. Increasing
regulatory expectations are leading to designs of
pharmaceutical cleanrooms for aseptic filling that include
an isolator or restricted access barrier system (RABS).
However, to illustrate the wider application of the risk
assessment method to more traditional cleanroom designs
found in other types of healthcare rooms, the following
cleanroom and manufacturing method is used as an
example.
1 Vials are aseptically filled with 2 cm3 of aqueous
solution, and sealed with sterile closures. This is
carried out in batches of 4000, which take about 4
hours to process.
2 Eight litres of an aqueous solution of the active
ingredient is prepared in an adjacent preparation
cleanroom and piped from the preparation vessel
through a sterilised, sterilising-grade filter, and into
the filling workstation. An aseptic connection is made
in the workstation with the product-filling equipment
before filling starts.
3 The vials are sterilised in a depyrogenation tunnel
from which they exit, and are conveyed through a
UDAF workstation (EU Guidelines to Good
Manufacturing Practice (GGMP) Grade A), which is
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known in this article as the ‘filling workstation’. The
vials, which have an inner neck area of 2 cm2, are
automatically filled in the filling workstation and
closed by a stopper. The vials are open in the filling
workstation to airborne contamination for 600 s.
4 The filling workstation is situated in a non-
unidirectional airflow cleanroom (EU GGMP Grade
B) which is known as the ‘filling room’. The filling
room has a volume of 300 m3 and an air supply of 3.33
m3/s of HEPA-filtered air (40 air changes per hour).
5 Two people work in the filling cleanroom and one of
these attends to the filling operation within the
workstation. Access into the filling workstation is
through plastic-strip curtains that hang round the
perimeter and down to just above the floor.
Interventions may occur when there are problems with
the filling line, and these are normally corrected by
sterilised long forceps.
6 Vial stoppers are held in a hopper that has a capacity of
1000 stoppers, and replenished every hour.
7 Personnel wear cleanroom clothing consisting of a
one-piece polyester coverall with full hood, overboots
and mask. Sterilised, latex, double sets of gloves are
worn over disinfected hands.
8 Hard surfaces, which do not come into contact with the
product containers or closures, are disinfected. Hard
surfaces, such as pipework that contacts the product
solution, and product-contacting surfaces, such as the
sterile vial closures, storage hopper, forceps, and
track-ways, are sterilised.
Degree of risk from sources of surface
and liquid microbial contamination in a
cleanroom
Shown in Figure 1 are the main surface and liquid sources
of microbial contamination of a product, along with
methods of controlling microbial concentrations and
transfer. The source of most, if not all, of microbes in a
cleanroom is people, who are considered the prime source.
Also included are sources external to the cleanroom that
may be the cause of contamination in the primary product
and containers. The sources which directly contact product
are within the UDAF workstation and are known as
primary sources. The floor is also included as it is within
the workstation, but it is not a primary source, as microbes
on the floor’s surface are firstly dispersed into the air by
walking, and then transferred by air to product. Also given
in Figure 1, for the sake of completeness, are methods of
controlling airborne transfer of MCPs to surfaces.
Not shown in Figure 1, or considered in this article, are
secondary sources, e.g. walls, doors, trolleys, tables,
disinfectant cans, etc., whose surface microbes do not
directly contact the product but do so through an
Figure 1. Risk diagram showing sources of surface and liquid microbial contamination along with control methods.
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intermediate vector. These secondary sources are too
numerous to be considered, but are usually less important
than primary sources as their microbes are subject to an
additional transfer step associated with an intermediate
vector. However, the last vector which contacts the
product will be one of the primary sources, with gloves the
main one, and the degree of risk can therefore be
indirectly ascertained by a risk assessment of the primary
sources, particularly gloves.
Should it be thought necessary, the NMDSC from
secondary sources can be calculated. Equation 2 can be
used to calculate the number of source microbes deposited
onto an intermediate vector surface, and the surface
concentration on the vector can then be used to calculate the
NMDSC onto product. The NMD can also be calculated for
mixed routes of transfer, such as surface contact and liquid
transfer, or surface contact and air transfer, as demonstrated
in the "Pipework, filling tubes and needles" and the
"Microbial dispersion from cleanroom floor" sections,
respectively.
The microbial sources shown in Figure 1 are tools,
gloves, cleanroom garments, product solution, solution
pathways (pipework, filling tubes and needles, etc.),
containers, and floor, and their degree of risk is now
assessed.
Tools
Sterilised tools include items such as long-length forceps
used to correct product vials that are displaced or fall
over, and the forceps may contact the product. The tools
will be sterilised and, as demonstrated in Annex A, the
surface concentration of microbes following sterilisation
and prior to use is negligible, and can be ignored.
However, the forceps may be contaminated by airborne
deposition, or by touching other contaminated surfaces
and, if they contact the vulnerable inner neck of the vial,
microbes may be transferred to product. The NMDSC can
be calculated as follows.
Gloves
In the cleanroom example, personnel wear disposable
double latex gloves. These gloves have been sterilised
by gamma radiation and, as demonstrated in Annex A,
the risk from surface microbes on unused gloves can be
ignored. However, there is a low possibility of skin
microbes being on glove surfaces because of
punctures17. Glove surfaces may also be contaminated
when donned, and by touching various surfaces during
the cleanroom manufacturing activities, as well as
deposition of airborne contamination. Gloves are
routinely disinfected during manufacture with sterile
70% isopropyl alcohol (IPA) to control the level of
surface contamination. Personnel are instructed never to
contact product with gloves, but it is useful to consider
what may occur if the vulnerable inner neck area of
vials is touched by gloves, and the NMDSC can be
calculated as follows.
Cleanroom garments
Garments are sterilised by radiation prior to use and, as
shown in Annex A, they will be effectively free of
microbes when unused. However, their surface may be
contaminated when donned, touched by contaminated
surfaces during manufacturing, or from microbes
depositing from the air. It is expected that the use of
long-length sterilised tools and good aseptic practices
will prevent garments contacting product. However, if
they accidently contact the vial, it is useful to know the
degree of risk, and the NMDSC can be calculated as
follows. 
Risk factor Assessment
1. Microbial  The microbial concentration on sterile 
 concentration on  surfaces was determined by sampling 
 forceps surface  after completion of manufacturing and 
 (number/cm2) will, therefore, represent the worst case 
  concentrations. From 38,062 samples, 
  one microbe was recovered. The 
  forceps had a contact area with the 
  sampling media of 1.2 cm2, which 
  gives a surface concentration of  
  2.2 x 10-5/cm2
2. Transfer  As discussed in the “Calculation of 
 coefficient microbial deposition onto a product” 
  section, the transfer coefficient 
  between stainless steel and glass 
  surfaces is assumed to be 0.2
3. Area of contact  The area of the forceps that makes 
 (cm2) contact with the inner neck of the vial 
  was measured and found to be 0.3 cm2
4. Number of  At worst, the internal neck area is 
 contacts contacted 10 times per 4000 containers, 
  which is a frequency of 2.5 x 10-3
Using Equation 2, the NMDSC is:
NMDSC = c*p*a*n = 2.2 x 10-5 * 0.2 * 0.3 * 2.5 x 10-3  = 3.3 x 10-9
Risk factor Assessment
1. Microbial  The post-manufacture measurement of 
 concentration on  the microbial concentration of five finger 
 glove surface  tips gives an average of 3.9 x 10-3/cm2. 
 (number/cm2) The five finger tips have a total surface 
  area of approximately 7.5 cm2, and so 
  the glove surface concentration is 
  5.2 x 10-4 /cm2 
2. Transfer  As discussed in the “Calculation of 
 coefficient microbial deposition onto a product” 
  section, the transfer coefficient between 
  gloves and vials is assumed to be 0.2, 
  and all contamination transferred enters 
  the product
3. Area of contact  The area of contact between a single 
 (cm2) glove tip and the inner neck of the vial 
  was measured and estimated to be 
  0.5 cm2
4. Number of  At worst, the glove tip might accidently 
 contacts contact the internal neck area 1 per 
  4000 containers, which is a frequency 
  of 2.5 x 10-4
Using Equation 2, the NMDSC can be calculated;
NMDSC = c*p*a*n = 5.3 x 10-4 * 0.2 * 0.5 * 2.5 x 10-4  = 1.3 x 10-8
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Filtered aqueous product solution
The solution of primary product is a potential source of
microbial contamination and is filtered through a sterilised,
sterilising-grade filter of the membrane type. Pre- and post-
use integrity testing of the filter is carried out using an
automated test unit that measures the rate of diffusive gas
flow. This measurement is directly related to a bacterial
challenge test performed by the filter manufacturer, where
the filter is challenged with Brevundimonas diminuta, with
a size of approximately 0.3 µm. Filters are required2 to
retain a challenge of 1 x 107 bacteria per cm2 of filter area.
The number of microbes deposited (NMDL) in product can
be calculated as follows.
Pipework, filling tubes and needles
The product solution is transferred from the sterilising-
grade filter to the filling point through a flexible transfer
pipe that is connected to filling needles. The flexible pipe
and needles are decontaminated and steam sterilised at
121°C. The internal surface of all these items prior to
sterilisation has been determined experimentally to have
14 microbes and, as calculated in Annex A1, the number
of microbes likely to survive steam sterilisation is 10-19. If
all of these microbes are washed off the pipework by the
passage of 8000 cm3 of product solution, the concentration
of microbes in the product solution will be 1.3 x 10-23 per
cm3. Such a low concentration can be ignored.
When the flexible pipe is connected to the filter, or
needles fitted into the filling machinery, the opening of a
pipe or needle surface may touch a glove, and microbial
transfer may occur. Any microbes transferred are assumed
to mix with product solution and be subsequently
dispensed into the vials. The area of the glove that contacts
with the pipework is likely to be different from that of a
needle opening. However, to avoid multiple calculations,
the area of 0.5 cm2, previously used in the “Gloves” section
when a glove touches vials, is again used.
The NMD is calculated in two stages, namely, glove to
pipework or needles, and then from pipework or needles
to product.
Risk factor Assessment
1. Microbial  The forearms and chest of garments are 
 concentration on  sampled after manufacturing using 
 garment surface  RODAC plates and an average 
 (number/cm2) concentration is 2.7 x 10-2 per 24 cm2, 
  which is a concentration of 
  1.1 x 10-3/cm2
2. Transfer  As discussed in the “Calculation of 
 coefficient microbial deposition onto a product” 
  section, the transfer coefficient between 
  the garment and the vulnerable inner 
  neck area of the vial is assumed to be 
  0.2. All contaminants were assumed to 
  enter the product
3. Area of contact  The area of contact between a garment 
 (cm2) and the vulnerable neck area of the 
  container was measured and estimate 
  to be about 0.5 cm2
4. Number of  At worst, the contact of the garment with 
 contact the internal neck area of the container is 
  assumed to be 1 contact per 4000 
  containers, which is a frequency of 
  2.5 x 10-4
Using Equation 2, the NMDSC can be calculated;
NMDSC = c*p*a*n = 1.1 x 10-3 * 0.2 * 0.5 * 2.5 x 10-4  = 2.8 x 10-8
Risk factor Assessment
1. Microbial  The maximum concentration, prior to 
 concentration in  sterile filtration, is determined 
 the product  experimentally to be 10/cm3
 solution 
 (number/cm3)
2. Transfer  The filter has a total filtration area of 
 coefficient  1000 cm2, and required to retain a 
  challenge of 1010 bacteria. The transfer 
  coefficient across the filter is, therefore, 
  1 x10-10. Although there may be 
  deposition of microbes throughout the 
  pipework from filter to filling point, this 
  will be very small compared to the 
  removal efficiency of the filter, and is 
  ignored
3. Volume of product  2 cm3
 solution dispensed 
 into vial (cm3)
Using Equation 4, the NMDL can be calculated;
NMDL = c*p*vc = 10 * 1 x 10-10 * 2 =  2.0 x 10-9
Risk factor Assessment
1. Microbial  The post-manufacture measurement of 
 concentration on  the microbial concentration of five finger 
 glove surface  tips gives an average of 3.9 x 10-3/cm2. 
 (number/cm2) The five finger tips have a total surface 
  area of approximately 7.5 cm2, and so 
  the glove surface concentration is 
  5.2 x 10-4 /cm2
2. Transfer  As discussed in the “Calculation of 
 coefficient microbial deposition onto a product” 
  section, the transfer coefficient between 
  gloves and pipework or needles is 
  assumed to be 0.2
3. Area of contact  An area of 0.5 cm2 was assumed
 (cm2)  
4. Number of  The frequency of contact is unlikely to 
 contacts exceed 1 contact per filling batch of 
  4000 vials, which is a frequency of 
  2.5 x 10-4
Using Equation 2, the NMDSC onto the pipe or needle opening 
can be calculated as follows:
NMDSC = c*p*a*n = 5.2 x 10-4* 0.2 * 0.5 * 2.5 x 10-4 = 1.3 x 10-8
The calculation in the row above shows that 1.3 x 10-8 MCPs 
are transferred to the pipe and needle openings and these are 
assumed to enter the product solution. The number that will 
enter a product by liquid transfer can now be calculated
5. Microbial  The product solution passes through the 
 concentration in  internal areas of pipework and needles, 
 product solution  all microbes are assumed to be washed 
 (number/cm3) and mixed into the product solution, and 
  the concentration in the solution of 
  4000 cm3 is 1.3 x 10-8 ÷ 4000 = 
  1.6 x 10-12/cm2
6. Transfer  All microbes introduced by contact are
 coefficient assumed to be swept by product 
  solution into the containers and the 
  transfer coefficient is 1
7 Volume of product  2 cm3
 solution dispensed 
 into vial (cm3) 
Using Equation 4, the NMDL can be calculated;
NMDL = c*p*v = 1.6 x 10-12 * 1 * 2 =  3.3 x 10-12
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Product vials
Following decontamination in an automated washing unit,
the vials are transferred to the filling workstation through
a depyrogenation tunnel, where they are sterilised. The
possibility that microbes can survive within the vial after
sterilisation can be calculated using the method given in
Annex A.
The maximum microbial concentration on the inner,
product-contacting surface of each vial, following
decontamination and prior to depyrogenation, was
determined experimentally to be 10. As calculated in
Annex A2, a dry heat sterilisation cycle of 170°C for 2
hours would reduce this to a concentration of about 
1 x 10-119. However, the depyrogenation cycle uses a
temperature of 250°C for 30 minutes and this additional
heat will decrease the microbial concentration to about 1
x10-300000 per vial. As these microbes are within the vial,
and there is no transfer coefficient to be considered, the
NMDSC will remain at about 1 x 10-300000.
Microbial dispersion from cleanroom floor 
The transfer of microbes from cleanroom floor to product
occurs in two stages. MCPs are dispersed into the air by
contact of shoes with the floor, and then transmitted
through the air to the product, where they may deposit.
The concentration of airborne microbes in the air of the
filling cleanroom and filling workstation that have been
dispersed from a floor is calculated in Annex B, and can
now be used to calculate the NMDA.
Filling cleanroom 
The concentration of MCPs dispersed into the cleanroom
air from the floor is calculated in Annex B. Assuming a
microbial concentration on the floor of 1.2 x 10-4/cm2, and
two people walking about for half of the total
manufacturing time, the number of MCPs dispersed into
the air in the filling cleanroom is calculated. These MCPs
mix with room air, and the airborne concentration of
microbes in the filling cleanroom that is derived from the
floor has been calculated to be 6.3 x 10-6/m3 (6.3 x 
10-12/cm3).
For the airborne MCPs in the filling cleanroom to reach
a product, they have to be transmitted across the curtains
and the UDAF within the filling workstation, and
deposited into a container. People may work through the
curtain, or enter the workstation to attend to containers
and machinery. Movement through the curtain and within
the UDAF allows airborne MCPs from the filling
cleanroom to be transmitted to product. Experiments
carried out by Ljungqvist and Reinmuller18 have shown
the proportion of airborne particles released outside the
workstation that reached the product when personnel were
working, was about 1 x 10-4; this proportion is the transfer
coefficient. The NMDA dispersed from the floor of the
filling cleanroom and deposited into the vial by the
airborne route can be calculated as follows.
Filling workstation
In the filling workstation, the mechanism of dispersion of
MCPs from floor to air by walking is the same as the
filling cleanroom. However, the walking activity is
reduced, as is the microbial concentration on the floor, and
this information is used in Annex B to calculate the
dispersion rate from the floor. Because of the downward
flow of UDAF, the MCPs dispersed from the floor will not
mix with all of the air in the filling workstation, but only
with air close to the floor. The airborne concentration
above the floor has been calculated in Annex B to be 2.3 x
10-7/m3 (2.3 x 10-13/cm3).
It is now necessary to consider the transfer of the
airborne MCPs from the area near to the floor to vials at
the filling location. The experiments carried out by
Ljungqvist and Reinmuller18 did not investigate this exact
situation but found that the proportion that reached a
closures hopper from the floor area was about 1 x 10-3. It
may seem surprising that the proportion of MCPs that
reaches the closures or vials against the downflow of air
may be greater than that transmitted across the airflow
(found to be about 1 x 10-4). However, machinery can
disrupt the downward airflow and produce a turbulent
wake where particles can flow in the opposite direction to
the overall flow. The transfer of contamination in such
conditions can be complicated, and it is best determined
experimentally in the individual situation. However, it has
been assumed that in the worst condition, the transfer
coefficient is 1 x 10-3.
Risk factor Assessment
1. Concentration of  The airborne concentration of MCPs in 
 airborne MCPs  the filling cleanroom derived from the 
 dispersed from the  floor is 6.3 x 10-12/cm3 (see calculation 
 filling cleanroom  in Annex B)
 floor (no/cm3) 
2. Transfer  The transfer coefficient is assumed to 
 coefficient of  be 1 x 10-4
 MCP from filling 
 cleanroom to 
 product
3. Area of product The inner neck area of vial is 2 cm2
 exposed (cm2) 
4. Time of  The proportion of time that a person 
 deposition (s) works in the filling workstation is 0.1 of 
  the total time, and therefore the time 
  for the transfer of contamination from 
  the filling room (normally 600 s) is 
  reduced to 60 s
5. Deposition  The average setting velocity of MCPs
 velocity through  through the air and into the vial is 
 air of MCPs  assumed to be 0.46 cm/s (see the 
 (cm/s) “Calculation of microbial deposition 
  onto a product” section).
Using Equation 1, the NMDA can be calculated to be as follows:
NMDA = c*p*a*t*s = 6.3 x 10-12 * 1 x 10-4 * 2 * 60 * 0.46 = 
3.5 x 10-14
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Relative importance of sources of
contamination in a typical
pharmaceutical cleanroom
The NMDs from surface contact and liquid routes found
in the example cleanroom are given in Table 1.
Discussion and conclusions
The method of ascertaining the degree of risk from
sources of microbial contamination in a cleanroom is
carried out by calculating the number of MCPs deposited
(NMD) into, or onto, a product by means of equations
presented in the introduction. A previous article11 has
considered the degree of risk from airborne sources and
this article ascertains the risk from surface and liquid
sources. 
To illustrate the method, a pharmaceutical cleanroom is
used in which batches of vials are aseptically filled in a
UDAF workstation. Cleanrooms used for aseptic filling are
now being designed with isolators and RABS but the
cleanroom used in the example allows the demonstration
of the risk assessment in a wider spectrum of cleanroom
design and manufacturing methods. However, if a different
cleanroom or manufacturing process is to be considered,
the risk assessment must be carried out for that cleanroom.
The equations used to calculate the NMD from
surface contact or liquids are fundamental, and if the
input into the equations is correct then the result will be
exact. Some of the equations variables (risk factors) will
be known, e.g. the horizontal area of product exposed to
airborne contamination, and others may need an
additional collection of information, such as the
concentration of MCPs on surfaces and in liquids. The
transfer coefficient is a more difficult variable to
ascertain, as information is not readily available. The
values of the airborne transfer coefficient used in this
article are obtained from the results of Ljungvist and
Reinmuller18, but we recommend further experiments to
extend this knowledge. The surface transfer coefficients
are based on our experimental results16, which
determined that in the worst case situation the surface
transfer coefficient was unlikely to be greater than 0.2.
The values of the transfer coefficients are, therefore,
reasonable estimates. However, if the required risk
variables cannot be obtained, and estimates based on an
informed estimate, the resulting risk assessment is
almost certain to be more accurate than a risk
assessment based on descriptors and risk scores.
It can be seen in Table 1 that the highest degree of
risk from surface contact and liquid sources in the
cleanroom example occurs if the vulnerable area of the
product is touched by the gloves or garments worn by
the cleanroom personnel. Personnel are trained to avoid
such contact but the calculation shows what can occur if
mistakes are made, and the NMDSC is in the region of
10-8, i.e. one product in every 108 may be contaminated
by microbes. However, if contact is made with an
Risk factor Assessment
1. Concentration of  The airborne concentration of MCPs 
 airborne MCPs  just above the floor that is derived from 
 derived from filling  the workstation floor by walking is 
 workstation floor  2.3 x 10-13 /cm3
 (no/cm3) 
2. Transfer  The transfer coefficient is assumed to 
 coefficient of  be 1 x 10-3
 MCP from around 
 the floor to vial
3. Area of product  The inner neck area of vial is 2 cm2
 exposed (cm2) 
4. Time of airborne  The proportion of time that a person 
 deposition (s) works in the filling workstation is 0.1 of 
  the total time, and therefore the time for 
  the transfer of contamination from the 
  filling room (normally 600 s) is reduced 
  to 60 s
5. Settling velocity  The settling velocity through air and into
 of MCPs through  a vial is 0.46 cm/s
 air (cm/s) 
Using Equation 1, the NMDA can be calculated to be as follows:
NMDA = c*p*a*t*s = 2.3 x 10-13 * 1 x 10-3 * 2 * 60 * 0.46 = 
1.3 x 10-14
Table 1. Importance of sources of surface contact and liquid contamination in a pharmaceutical cleanroom.
Risk importance Source of microbial contamination NMD from surface 
contact and liquids 
1 Contact of product with cleanroom garments* 2.8 x 10-8
2 Contact of product with double gloves* 1.3 x 10-8
3 Contact of product with ‘sterile’ tools, e.g. forceps with container neck 3.3 x 10-9
4 Filtered aqueous product solution 2 x 10-9
5 Liquid contamination through contact of gloves with pipework and filling needles* 3.3 x 10-12
6 Floor in the UDAF filling workstation EU GGMP grade A 1.3 x 10-14
7 Floor in the non-unidirectional airflow filling room EU GGMP grade B 3.5 x 10-14
8 Sterilised product containers 1 x 10-300000
*Under normal control conditions, the risk will be much smaller. However, it is useful to determine the degree of risk when normal
control measures have been breached and these contamination rates relate to this.
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inanimate item, such as a sterilised tool or ancillary
item, e.g. forceps, the NMDSC will be about 10-9. If the
personnel’s gloves make contact with vulnerable areas
of pipework or needle assembly, during the set-up of the
filling equipment, the NMDSC is likely to be about 10-12.
When the primary solution of product is filtered by a
single sterilised sterilising grade filter, the NMDL is
likely to be less than about 10-9. The NMD from the
floor in both the filling cleanroom and the filling
workstation is negligible and about 10-14. The risk from
sterilised (depyrogenation cycle) containers is infinitely
low (1 x 10-300000).
In a previous article, Whyte and Eaton11 discussed and
calculated the NMDA from airborne sources. A further
article will consider all sources of microbiological
contamination in various types of cleanrooms, i.e. those
transferred by air, surface contact, and liquid routes. Also
discussed will be methods used to reduce the degree of
risk, where it is considered too high.
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Annex A: Calculation of the reduction of
surface microbial concentrations by
sterilisation
In the main body of this article, it has been assumed that
surfaces of microbial sources, such as gloves, tools and
garments, which are unused and sterilised by steam, dry
heat and radiation, have no surface micro-organisms, or
such an extremely small number that it will make no
significant contribution to microbial contamination of
product. The justification of this assumption is contained
in this annex. With knowledge of sterilisation kinetics, the
number of microbes likely to survive sterilisation can be
calculated for the three sterilisation processes.
Steam sterilisation
The number of microbes that survive steam sterilisation
can be calculated by means of the following equation19.
Equation A1
Log B = Log A – (F0 /D)
Where, A = number of microbes at the start of sterilisation,
B = number of microbes at the end of sterilisation, F0 =
equivalent exposure time, and D = D-value
The values of F0 and D are ascertained as follows. 
F
o
: For steam sterilisation, 121°C is the reference
temperature used to calculate the effectiveness of
sterilisation at other temperatures, and calculated by
Equation A2:
Equation A2
F0 = L x t
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Where, L = lethal rate, and t = sterilisation time.
At 121°C, the lethal rate (L) has a value of 1 and,
therefore, for sterilisation at 121°C for 20 minutes, the F0
value is 20 minutes.
D value: The D-value is the time required, at a specified
temperature, to reduce the microbial population by one
logarithmic value (90% reduction). The D-value varies
according to the type of micro-organism but at 121°C,
most microbes die instantly. However, bacterial spores
have a much greater thermal resistance, and a D-value of 1
minute is often assumed19. This is a reasonable value, as
spores isolated in cleanrooms are likely to be the
mesophilic type that is more susceptible to heat treatment
and are likely to be less than 5% of the microflora found in
cleanrooms. 
If appropriate values of F0 and D are used in Equation
A1, the number of surviving organisms can be calculated.
For example, if the number of microbes in the internal
surfaces of pipework and needles is 14, the number of
surviving microbes is 10-19. 
Dry heat sterilisation
The number of microbes remaining after dry heat
sterilisation can be calculated by means of the following
equation20.
Equation A3
Log B = Log A – (FH /D)
Where, FH = equivalent exposure time in dry heat.
For dry heat sterilisation, 170°C is the reference
temperature from which the effectiveness of sterilisation
at other temperatures can be calculated by means of
Equation A4.
Equation A4
FH = L x t
For dry heat sterilisation at 170°C, the lethal
rate (L) is 1. Therefore, using Equation A4,
the FH value for a cycle of 120 minutes at
170°C is 120. At a dry heat temperature of
170°C, a D-value of 1 minute is assumed20. 
Using Equation A3, the number of
surviving micro-organisms, when the
maximum number on the internal surface of
an object such as a container is 10, can be
calculated to be 10-119. However, containers
that are subjected to the depyrogenation
conditions of 250°C for 30 minutes will have
an increased lethal rate at this temperature that
can be calculated from use of Equation A5.
Equation A5
L = 10 [(To-Tb)/Z] 
Where, TO = sterilisation temperature utilised, Tb = base
temperature, and Z = z value.
The z-value is the temperature coefficient of microbial
destruction and is the number of degrees Centigrade
required to cause a 10-fold increase in the sterilisation
rate, and is assumed to be 20°C20. Utilising a Tb value of
170°C, the lethal rate at 250°C is calculated to be 104. The
FH value for a 30 minute cycle at this temperature is then
calculated by Equation A4 and found to be 3 x105. Under
these conditions, the number of surviving microbes in
each container can then be calculated using Equation A3.
As an example, if the D-value at a dry heat temperature of
250°C for 1 minute is considered with a microbial
concentration on the internal surface of a vial of 10, the
number of surviving organisms is 10-299999.
Radiation sterilisation
Cleanroom garments are normally sterilised by gamma
radiation, using a minimum radiation dose of 25 kGy. The
number of microbes on a cleanroom garments prior to
sterilisation can be determined by immersing and
agitating the garment in liquid, filtering the liquid, and
incubating the filter. A one-piece coverall is the item of
cleanroom clothing with the largest area and, therefore,
the highest bioburden, and shown to have a bioburden
prior to sterilisation of 190 microbes. 
The radiation dose required to achieve a given
sterility assurance level up to 1 x 10-6, for a range of
average bioburdens of microbes with a standard
distribution of resistance against radiation, is given in
table 5 of ISO 11137-221. For a bioburden of 190
microbes, this is represented graphically in Figure A1.
By extrapolation of the graph, it can be seen that the
number of surviving microbes after exposure to 25 kGy
is approximately 1 x 10-7. As the one-piece coverall has
an external surface area of about 16,000 cm2, and hence a
Figure A1. Radiation dose required to achieve a sterility assurance level for an
average bio-burden of 190, extrapolated for a dose of 25 kGy.
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total internal and external area of about 32,000 cm2, the
concentration of surviving micro-organisms on the
garment surface can be assumed to be 1 x 10-7 ÷ 32,000 =
3.1 x 10-12/cm2.
Annex B: Number of MCPs dispersed
from cleanroom floor 
To calculate the risk to product from MCPs dispersed by
personnel walking on a floor, it is necessary to know the
concentration of MCPs in the air of a clean zone that are
derived from the floor. These are calculated in this annex.
The number of MCPs dispersed from a floor by
walking has been investigated by Whyte et al22 who
showed it to be dependent on the total number of steps per
second taken by all of the personnel in the room, the shoe
area, and the ‘redispersion fraction’ (RF), which is the
fraction of MCPs on the floor surface that is dispersed by
one step. The dispersion rate can be calculated as follows.
Equation B1
DF = CF xAS x RF x N x W x P
Where, DF = microbial dispersion rate, CF = concentration
of microbes on floor surface, AS = area of shoe in contact
with floor, RF = redispersion fraction, N = number of
people in room, W = walking rate (number of steps/s), and
P = proportion of time spent walking.
Knowing the dispersion rate of MCPs from the floor by
walking, the airborne concentration of MCPs in both the
filling cleanroom and filling workstation can be calculated
as follows.
Filling cleanroom 
When MCPs are dispersed from the cleanroom floor, they
will mix with the air in the non-unidirectional airflow
filling cleanroom to give a reasonably constant
concentration across the room. The airborne concentration
of MCPs can be calculated by Equation B2 derived by
Whyte et al22 to take account of dilution by the air supply
to the cleanroom and the loss by gravitational re-
deposition onto the floor.
Equation B2
Airborne 𝐷𝐹 𝐶𝐹∗𝐴𝑆∗𝑅𝐹∗𝑁∗𝑊∗𝑃
concentration of = 1111 = 11111111
floor-derived MCPs/m3 𝑄+(𝑉𝐷∗𝐴) 𝑄+(𝑉𝐷∗𝐴)
Where, Q is the rate of air supply volume (m3/s), VD is the
deposition velocity of MCPs (0.0046 m/s), and A is the
deposition area (m2) in the room (normally the floor).
The meaning and the value of the deposition velocity of
MCPs, which is 0.0046 m/s, is discussed in Part 1 of these
articles11 and the experiment to determine the redispersion
factor, which was 0.0012, is described by Whyte et al22.
In the cleanroom example being studied, the following
is assumed: two people walk about the filling cleanroom
for a proportion of 0.5 of the time, at a rate of 1.5 steps per
second, and have shoes with a contact area of 110 cm2
(0.011 m2). The redispersion fraction is 0.0012, the air
supply rate is 3.33 m3/s, and the floor area is 100 m2 with a
microbial surface concentration of 1.2/m2. The airborne
concentration of MCPs in the filling cleanroom in the
steady-state condition during manufacturing (C) is,
therefore, as follows.
1.2*0.011*0.0012*2*1.5*0.5
C = 111111111111 = 6.3x10-6/m3 = 6.3x10-12/cm3
3.33+(0.0046×100)
This concentration is used in the “Filling cleanroom”
subsection of the “Microbial dispersion from cleanroom
floor” section to calculate the NMDA when the source is
the filling cleanroom floor.
Filling workstation
In the filling workstation, the mechanism of dispersion of
MCPs from the floor into air is the same as the filling
cleanroom, and the number of MCPs dispersed per second
can also be calculated by Equation B1. However, only one
person attends to the filling line, and spends a smaller
proportion of their total time (0.1) working and walking in
the filling workstation. Their walking rate is again 1.5/s
with a shoe area of 0.011 m2. The microbial concentration
on the floor of the filling workstation is lower than the
filling room, and 0.42/m2. The microbial dispersion rate
(DF) is therefore as follows.
DF = CF x AS x RF x N x W x P =
0.42*0.011*0.0012*1*1.5*0.1 = 8.3 x 10-7/s
Because of the downward UDAF in the filling
workstation, the MCPs dispersed from the floor will not
mix with all of the air in the workstation but only with the
air above the floor. The area of the air supply filters is 3 m
x 3 m, and air is discharged from the filters at a velocity of
0.4 m/s; there is, therefore, an air supply volume of
3.6 m3/s. As the UDAF does not pass through the floor, the
UDAF will change to non-unidirectional airflow above
the floor and turbulently mix with the dispersed MCPs.
The concentration of MCPs close to the floor can,
therefore, be calculated in the steady-state condition by
use of Equation B2 but, as the floor area is so small, the
MCP deposition on the floor area is ignored.
Airborne concentration of floor-derived MCPs close to floor = 
microbial dispersion rate from floor/s 8.3 x 10−7/s
111111111111111 = 11111
air supply volume rate (m3/s) 3.6m3/s 
= 2.3 x 10-7/m3 = 2.3 x 10-13/cm3
The NMDA is calculated in the “Filling workstation”
subsection of the “Microbial dispersion from cleanroom
floor” section from this concentration.
